Agilent Technologies (NYSE:A) Price Target Increased to $130.00 by Analysts at Evercore ISI

Agilent Technologies (NYSE:A) had its price target raised by research analysts at Evercore ISI from $126.00 to $130.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm presently has an “in-line” rating on the medical research company’s stock. Evercore ISI’s price target would indicate a potential upside of 1.90% from the company’s previous close.

A has been the topic of a number of other reports. Jefferies Financial Group reiterated a “hold” rating and issued a $135.00 price target (down from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. UBS Group dropped their target price on Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating on the stock in a research note on Thursday, May 30th. Citigroup decreased their price target on shares of Agilent Technologies from $145.00 to $135.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Barclays decreased their target price on shares of Agilent Technologies from $135.00 to $125.00 and set an “underweight” rating for the company in a research report on Friday, May 31st. Finally, Wolfe Research cut Agilent Technologies from an “outperform” rating to a “peer perform” rating in a research report on Thursday, June 27th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $137.13.

Agilent Technologies Stock Up 0.1 %

Shares of A traded up $0.18 during midday trading on Tuesday, reaching $127.58. 217,461 shares of the stock were exchanged, compared to its average volume of 1,781,996. The company has a market capitalization of $37.22 billion, a P/E ratio of 30.16, a PEG ratio of 4.40 and a beta of 1.05. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 0.34. Agilent Technologies has a 52 week low of $96.80 and a 52 week high of $155.35. The company’s 50 day moving average is $139.56 and its two-hundred day moving average is $138.50.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 29th. The medical research company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.19 by $0.03. Agilent Technologies had a net margin of 18.84% and a return on equity of 26.25%. The business had revenue of $1.57 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter last year, the firm posted $1.27 EPS. The company’s revenue for the quarter was down 8.4% on a year-over-year basis. On average, sell-side analysts anticipate that Agilent Technologies will post 5.25 earnings per share for the current year.

Insider Buying and Selling

In other news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now directly owns 49,486 shares of the company’s stock, valued at $6,595,494.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In related news, CEO Padraig Mcdonnell sold 1,958 shares of Agilent Technologies stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the transaction, the chief executive officer now directly owns 25,185 shares in the company, valued at $3,274,050. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Dominique Grau sold 15,000 shares of the company’s stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total transaction of $1,999,200.00. Following the sale, the senior vice president now owns 49,486 shares in the company, valued at $6,595,494.08. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Livelsberger Financial Advisory purchased a new stake in shares of Agilent Technologies during the fourth quarter worth approximately $26,000. MV Capital Management Inc. lifted its position in shares of Agilent Technologies by 120.7% during the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after acquiring an additional 105 shares during the period. VisionPoint Advisory Group LLC purchased a new stake in shares of Agilent Technologies during the 4th quarter worth approximately $29,000. Rise Advisors LLC increased its stake in Agilent Technologies by 527.8% in the 1st quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock valued at $33,000 after purchasing an additional 190 shares in the last quarter. Finally, YHB Investment Advisors Inc. purchased a new position in Agilent Technologies in the 1st quarter valued at approximately $34,000.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.